University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion — Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion?

University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion conducted?

University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma.

Is University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion accredited by Crixeo Health?

University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh Medical Center William M. Cooper Ambulatory Care Pavillion?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.